p 481.20 <%= Resources.Global.txtDown %>
Updated 13/07/2018
Change % -0.58% Stock price decreasing
Change -2.80 Stock price decreasing
Volume 950,393
High P 497.60
Low P 480.20
Open P 485.60
ISIN GB0001001592
Prev close P 484.00
# of shares 386.96M
Market cap 186,203M GBX

Market closed
Market is open (until 16:30) - Delayed 15 min
Price development Latest 1 week 1 month 3 months 6 months 1 year
  481.20 -2.7% Stock price decreasing -7.5% Stock price decreasing -24.8% Stock price decreasing -35.9% Stock price decreasing -28.4% Stock price decreasing
Powered by TradingView

Company profile

BTG PLC is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. The revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
16 July 2018 07:37:31
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180712.1 - EUROWEB3 - 2018-07-16 08:37:31 - 2018-07-16 07:37:31 - 1000 - Website: OKAY